Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
4.530
-0.100 (-2.16%)
At close: Feb 21, 2025, 4:00 PM
4.480
-0.050 (-1.10%)
After-hours: Feb 21, 2025, 4:24 PM EST
Rezolute Employees
Rezolute had 59 employees as of June 30, 2024. The number of employees increased by 8 or 15.69% compared to the previous year.
Employees
59
Change (1Y)
8
Growth (1Y)
15.69%
Revenue / Employee
n/a
Profits / Employee
-$1,205,661
Market Cap
274.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
RZLT News
- 5 days ago - Rezolute: Late-Stage Study Targeting Hyperinsulinism - Seeking Alpha
- 10 days ago - Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 18 days ago - Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism - GlobeNewsWire
- 22 days ago - Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 2 months ago - Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Rezolute: Ersodetug Downstream Tech Could Ignite The Hyperinsulinism Market - Seeking Alpha
- 5 months ago - Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment - Benzinga